Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 5/20 | 0.78 |
| ▸ | ADRB1 | P08588 | 5/20 | 0.78 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.78 |
| ▸ | LMNA | P02545 | 2/20 | 0.78 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.78 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.78 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.78 |
| ▸ | TSHR | P16473 | 2/20 | 0.78 |
| ▸ | CNR1 | P21554 | 1/20 | 0.78 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.78 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.78 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.78 |
| ▸ | GLA | P06280 | 1/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.78 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.78 |
| ▸ | THPO | P40225 | 1/20 | 0.78 |
| ▸ | BLM | P54132 | 1/20 | 0.78 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.67 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.67 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10072155 | 1.00 | ADRB2 (0.78) | ADRB2ADRB1TDP1LMNAPMP22 | |
| SCHEMBL9628892 | 1.00 | ADRB2 (0.78) | ADRB2ADRB1TDP1LMNAPMP22 | |
| Hydrochloric Acid SCHEMBL6016823 | 0.99 | ADRB2 (0.76) | ADRB2ADRB1TDP1LMNAPMP22 | |
| SCHEMBL10961494 | 0.89 | ADRB2 (0.78) | ADRB2ADRB1TDP1LMNAPMP22 | |
| Atenolol SCHEMBL18120 | 0.88 | ADRB2 (1.00) | ADRB2ADRB1TDP1LMNAPMP22 | |
| SCHEMBL10737751 | 0.88 | ADRB2 (0.76) | ADRB2ADRB1TDP1LMNAPMP22 | |
| Atenolol SCHEMBL4362 | 0.88 | ADRB2 (1.00) | ADRB2ADRB1TDP1LMNAPMP22 | |
| SCHEMBL6016784 | 0.88 | ADRB2 (0.77) | ADRB2ADRB1TDP1LMNAPMP22 | |
| Atenolol SCHEMBL6509830 | 0.88 | ADRB2 (1.00) | ADRB2ADRB1TDP1LMNAPMP22 | |
| Esatenolol SCHEMBL4363 | 0.88 | ADRB2 (1.00) | ADRB2ADRB1TDP1LMNAPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111110854-A | Composition comprising a histamine release-promoting substance and an inhibitory compound | 黄泳华 | 2020-05-08 | — | — | CN | claimed |
| EP-0256586-B1 | PROCESS FOR THE PREPARATION OF ESTERS OF 4-(2,3-EPOXYPROPOXY)PHENYLACETIC ACID AND 4-(2-HYDROXY-3-ISOPROPYLAMINO-PROPOXY)PHENYLACETIC ACID AND/OR ATENOLOL IN STEREOSPECIFIC FORM | GIST-BROCADES N.V. (NL) | 1992-05-13 | — | — | EP | claimed |
| CN-1031397-A | The method of the stereospecific form of preparation 4-(2,3 one glycidoxy)-phenylacetate and 4-(different phenylamino one propoxy-of 2-hydroxyl-3-)-phenylacetate and/or 4-(2-hydroxyl-3-isopropylamino propoxy-)-phenylacetamide | GIST BROCADES NV (NL) | 1989-03-01 | — | — | CN | claimed |
| EP-0256586-A1 | Process for the preparation of esters of 4-(2,3-epoxypropoxy)phenylacetic acid and 4-(2-hydroxy-3-isopropylamino-propoxy)phenylacetic acid and/or atenolol in stereospecific form | GIST-BROCADES N.V. (NL) | 1988-02-24 | — | — | EP | claimed |
| CN-111110854-A | Composition comprising a histamine release-promoting substance and an inhibitory compound | 黄泳华 | 2020-05-08 | — | — | CN | disclosed |
| US-7229782-B1 | Antibodies specific to multiple beta blockers and methods for their use | LABONE, INC. (US) | 2007-06-12 | — | — | US | disclosed |
| US-7229782-B1 | Antibodies specific to multiple beta blockers and methods for their use | LABONE, INC. (US) | 2007-06-12 | — | — | US | disclosed |
| US-6680047-B2 | FOR USE IN ULTRASOUND IMAGING, CONTRAST AGENTS | AMERSHAM HEALTH AS (NO) | 2004-01-20 | — | — | US | disclosed |
| US-20020102217-A1 | Diagnostic/therapeutic agents | NYCOMED IMAGING AS | 2002-08-01 | — | — | US | disclosed |
| EP-1007101-A2 | IMPROVEMENTS IN OR RELATING TO DIAGNOSTIC/THERAPEUTIC AGENTS | Marsden, John Christopher (GB) | 2000-06-14 | — | — | EP | disclosed |
| WO-1998018500-A2 | IMPROVEMENTS IN OR RELATING TO DIAGNOSTIC/THERAPEUTIC AGENTS | MARSDEN, JOHN, CHRISTOPHER (GB) | 1998-05-07 | — | — | WO | disclosed |
| EP-0256586-B1 | PROCESS FOR THE PREPARATION OF ESTERS OF 4-(2,3-EPOXYPROPOXY)PHENYLACETIC ACID AND 4-(2-HYDROXY-3-ISOPROPYLAMINO-PROPOXY)PHENYLACETIC ACID AND/OR ATENOLOL IN STEREOSPECIFIC FORM | GIST-BROCADES N.V. (NL) | 1992-05-13 | — | — | EP | disclosed |
| EP-0256586-B1 | PROCESS FOR THE PREPARATION OF ESTERS OF 4-(2,3-EPOXYPROPOXY)PHENYLACETIC ACID AND 4-(2-HYDROXY-3-ISOPROPYLAMINO-PROPOXY)PHENYLACETIC ACID AND/OR ATENOLOL IN STEREOSPECIFIC FORM | GIST-BROCADES N.V. (NL) | 1992-05-13 | — | — | EP | disclosed |
| CN-1016074-B | PROCESS FOR PREPARING ESTERS OF 4-(2-HYDROXY-3-ISOPROPYLAMINO-PROPOXY) PHENYLACETIC ACID AND/OR ATENOLOL IN STEREOSPECIFIC FORM | GIST BROCADES NV (NL) | 1992-04-01 | — | — | CN | disclosed |
| EP-0256586-A1 | Process for the preparation of esters of 4-(2,3-epoxypropoxy)phenylacetic acid and 4-(2-hydroxy-3-isopropylamino-propoxy)phenylacetic acid and/or atenolol in stereospecific form | GIST-BROCADES N.V. (NL) | 1988-02-24 | — | — | EP | disclosed |
| EP-0256586-A1 | Process for the preparation of esters of 4-(2,3-epoxypropoxy)phenylacetic acid and 4-(2-hydroxy-3-isopropylamino-propoxy)phenylacetic acid and/or atenolol in stereospecific form | GIST-BROCADES N.V. (NL) | 1988-02-24 | — | — | EP | disclosed |